Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia

Fitoterapia

Volumn 82, Issue 7, 2011, Pages 976-982

  Feng, Ai Wen ^a,b   Yu, Chao ^a,b   Mao, Qing ^a,c   Li, Ning ^a,b   Li, Qiu Rong ^a,b   Li, Jie Shou ^a,b  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

GW9662; Ileum; Lipopolysaccharide; p38; PPAR ; SB202190

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; BERBERINE; CYCLOOXYGENASE 2 INHIBITOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ACUTE ENDOTOXEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG STRUCTURE; ENDOTOXEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE MUCOSA; WESTERN BLOTTING;

ACUTE DISEASE; ANILIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BERBERINE; COPTIS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENZYME INHIBITORS; IMIDAZOLES; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PPAR GAMMA; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME; UP-REGULATION;

RATTUS;

EID: 80052139394     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.05.013     Document Type: Article

References (42)

1. S. Kargman, S. Charleson, M. Cartwright, J. Frank, D. Riendeau, and J. Mancini Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts Gastroenterology 111 1996 445 454 (Pubitemid 26256734)
2. A. Grishin, J. Wang, D. Hackam, F. Qureshi, J. Upperman, and R. Zamora p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes Surgery 136 2004 329 335 (Pubitemid 39037673)
3. A.V. Grishin, J. Wang, D.A. Potoka, D.J. Hackam, J.S. Upperman, and P. Boyle Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway J Immunol 176 2006 580 588 (Pubitemid 43023306)
4. Y.S. Guner, C.J. Ochoa, J. Wang, X. Zhang, S. Steinhauser, and L. Stephenson Peroxynitrite-induced p38 MAPK pro-apoptotic signaling in enterocytes Biochem Biophys Res Commun 384 2009 221 225
5. T. Tanabe, and N. Tohnai Cyclooxygenase isozymes and their gene structures and expression Prostaglandins Other Lipid Mediat 68-69 2002 95 114 (Pubitemid 35247390)
6. G. Wu, J. Luo, J.S. Rana, R. Laham, F.W. Sellke, and J. Li Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells Cardiovasc Res 69 2006 512 519 (Pubitemid 43098807)
7. W.E. Longo, B. Erickson, N. Panesar, J.E. Mazuski, S. Robinson, and D.L. Kaminski The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation Mediators Inflamm 7 1998 373 380 (Pubitemid 29030349)
8. L.A. Moraes, L. Piqueras, and D. Bishop-Bailey Peroxisome proliferator-activated receptors and inflammation Pharmacol Ther 110 2006 371 385
9. C.S. Eun, D.S. Han, S.H. Lee, C.H. Paik, Y.W. Chung, and J. Lee Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway Dig Dis Sci 51 2006 693 697
10. C. Huin, L. Corriveau, A. Bianchi, J.M. Keller, P. Collet, and P. Kremarik-Bouillaud Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract J Histochem Cytochem 48 2000 603 611 (Pubitemid 30233184)
11. C.G. Su, X. Wen, S.T. Bailey, W. Jiang, S.M. Rangwala, and S.A. Keilbaugh A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J Clin Invest 104 1999 383 389 (Pubitemid 29534322)
12. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm Res 49 2000 497 505
13. N. Baregamian, J.M. Mourot, A.R. Ballard, B.M. Evers, and D.H. Chung PPAR-gamma agonist protects against intestinal injury during necrotizing enterocolitis Biochem Biophys Res Commun 379 2009 423 427
14. L. Dubuquoy, C. Rousseaux, X. Thuru, L. Peyrin-Biroulet, O. Romano, and P. Chavatte PPARgamma as a new therapeutic target in inflammatory bowel diseases Gut 55 2006 1341 1349 (Pubitemid 44277368)
15. S.K. Mohapatra, A.J. Guri, M. Climent, C. Vives, A. Carbo, and W.T. Horne Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease PLoS One 5 2010 e10215
16. K. Ban, and R.A. Kozar Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut J Leukoc Biol 84 2008 595 599
17. Y. Naito, T. Takagi, K. Uchiyama, O. Handa, N. Tomatsuri, and E. Imamoto Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats Redox Rep 7 2002 294 299 (Pubitemid 36032917)
18. O. De Backer, E. Elinck, E. Priem, L. Leybaert, and R.A. Lefebvre Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes J Pharmacol Exp Ther 331 2009 496 503
19. J. Tang, Y. Feng, S. Tsao, N. Wang, R. Curtain, and Y. Wang Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations J Ethnopharmacol 126 2009 5 17
20. I.A. Lee, Y.J. Hyun, and D.H. Kim Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-kappa B activation Eur J Pharmacol 648 2010 162 170
21. H. Zhou, and S. Mineshita The effect of berberine chloride on experimental colitis in rats in vivo and in vitro J Pharmacol Exp Ther 294 2000 822 829 (Pubitemid 30666829)
22. Q. Zhang, X.L. Piao, X.S. Piao, T. Lu, D. Wang, and S.W. Kim Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides Food Chem Toxicol 49 2011 61 69
23. K. Fukuda, Y. Hibiya, M. Mutoh, M. Koshiji, S. Akao, and H. Fujiwara Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells J Ethnopharmacol 66 1999 227 233 (Pubitemid 29307925)
24. Y. Kase, K. Saitoh, B. Makino, K. Hashimoto, A. Ishige, and Y. Komatsu Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components Phytother Res 13 1999 468 473 (Pubitemid 29445762)
25. C.L. Kuo, C.W. Chi, and T.Y. Liu The anti-inflammatory potential of berberine in vitro and in vivo Cancer Lett 203 2004 127 137
26. Q. Zhang, X.L. Piao, X.S. Piao, T. Lu, D. Wang, and S.W. Kim Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides Food Chem Toxicol 2010
27. M.K. Pandey, B. Sung, A.B. Kunnumakkara, G. Sethi, M.M. Chaturvedi, and B.B. Aggarwal Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis Cancer Res 68 2008 5370 5379
28. W. Liu, F. Tang, Y. Deng, X. Li, T. Lan, and X. Zhang Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition Mol Cell Biochem 325 2009 99 105
29. Z.Q. Huang, L.S. Wang, S. Meng, Y. Wang, T. Chen, and C.Q. Wang Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages Int J Cardiol 146 2011 153 158
30. F.L. Chen, Z.H. Yang, Y. Liu, L.X. Li, W.C. Liang, and X.C. Wang Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway Endocrine 33 2008 331 337
31. B.H. Choi, I.S. Ahn, Y.H. Kim, J.W. Park, S.Y. Lee, and C.K. Hyun Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte Exp Mol Med 38 2006 599 605
32. N. Keklikoglu c-Jun, Fra-2, and ATF-2 immunoreactivity in the jejunal tissues of the healthy rat Dig Dis Sci 53 2008 2680 2686
33. M. Fukata, A. Chen, A. Klepper, S. Krishnareddy, A.S. Vamadevan, and L.S. Thomas Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine Gastroenterology 131 2006 862 877 (Pubitemid 44316821)
34. L. Dubuquoy, E.A. Jansson, S. Deeb, S. Rakotobe, M. Karoui, and J.F. Colombel Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis Gastroenterology 124 2003 1265 1276 (Pubitemid 36531802)
35. Y. Liu, J. Huang, Y. Hou, H. Zhu, S. Zhao, and B. Ding Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs Br J Nutr 100 2008 552 560
36. M. Schwab, V. Reynders, S. Loitsch, D. Steinhilber, J. Stein, and O. Schroder Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling Mol Immunol 44 2007 3625 3632 (Pubitemid 46817672)
37. J. Zhou, and S. Zhou Berberine regulates peroxisome proliferator- activated receptors and positive transcription elongation factor b expression in diabetic adipocytes Eur J Pharmacol 649 2010 390 397
38. E.D. Hu, J.B. Kim, P. Sarraf, and B.M. Spiegelman Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma Science 274 1996 2100 2103 (Pubitemid 27020707)
39. C. Huang, Y. Zhang, Z. Gong, X. Sheng, Z. Li, and W. Zhang Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway Biochem Biophys Res Commun 348 2006 571 578 (Pubitemid 44209153)
40. J.Y. Zhou, S.W. Zhou, K.B. Zhang, J.L. Tang, L.X. Guang, and Y. Ying Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats Biol Pharm Bull 31 2008 1169 1176 (Pubitemid 351871171)
41. J.Y. Zhou, and S.W. Zhou Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae Yao Xue Xue Bao 42 2007 1243 1249
42. Y. Chen, Y. Li, Y. Wang, Y. Wen, and C. Sun Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions Metabolism 58 2009 1694 1702